<DOC>
	<DOCNO>NCT00020865</DOCNO>
	<brief_summary>RATIONALE : Levofloxacin may effective reduce fever control symptom neutropenia patient treat cancer . It yet know whether levofloxacin effective cefepime reduce fever control symptom neutropenia . PURPOSE : Randomized phase III trial compare effectiveness levofloxacin cefepime reduce fever control symptom neutropenia patient treat cancer .</brief_summary>
	<brief_title>Levofloxacin Compared With Cefepime Treating Cancer Patients With Fever Neutropenia</brief_title>
	<detailed_description>OBJECTIVES : I . Compare safety efficacy levofloxacin versus cefepime cancer patient fever neutropenia . II . Compare percentage patient whose fever defervesces sign symptom infection without therapeutic modification . III . Compare percentage survival patient treat 2 regimen therapeutic modification . IV . Compare overall survival patient treat 2 regimen regardless therapeutic modification . V. Compare time resolution fever patient treat regimen . VI . Compare microbiologic response pathogen site infection patient treat regimen . VII . Compare percentage patient whose fever defervesce resolution neutropenia ( absolute neutrophil count least 500/mm3 ) therapeutic modification . OUTLINE : This randomize , double-blind , multicenter study . Patients stratify accord type malignancy ( solid tumor , include lymphoma v leukemia ) , prior prophylactic antibiotic ( yes v ) , participate center . Patients randomize one two treatment arm . Arm I : Patients receive levofloxacin IV 90 minute daily 14-28 day . Arm II : Patients receive cefepime IV 30 minute every 8 hour 14-28 day . Patients may receive additional antifungal , antibacterial , antiviral therapy condition deteriorate , response see 72 hour , infection suspect documented . Patients follow 1-3 7-12 day 3-4 week . PROJECTED ACCRUAL : Approximately 260-400 patient ( 130-200 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Cefepime</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis malignancy Solid tumor ( include lymphoma ) leukemia Hospitalized anticipate remain hospitalized study Febrile define oral temperature least 100.4 degree F ( 38 degree C ) 2 occasion within 24 hour OR least 100.8 degree F ( 38.2 degree C ) single read No obvious noninfectious cause fever ( e.g. , platelet transfusion ) Neutropenic , define absolute neutrophil count ( ANC ) currently less 500/mm3 OR anticipate less 500/mm3 within 24 hour study entry Anticipated ANC le 500/mm3 least 72 hour No neutropenia unassociated malignancy No chronic neutropenia No neutropenia anticipate last 14 day No acute myelogenous leukemia unless receive consolidation chemotherapy induction dose prolong neutropenia 3 week No infection due identify organism No high likelihood infection due anaerobic organism , include intraabdominal infection perirectal abscess admission No known osteomyelitis No requirement new antifungal agent PATIENT CHARACTERISTICS : Age : 18 Performance status : Not specify Life expectancy : At least 14 day Hematopoietic : See Disease Characteristics Hepatic : Not specify Renal : Creatinine clearance least 20 mL/min No oliguria ( urine output le 20 mL/hour ) unresponsive fluid challenge Cardiovascular : No shock hypotension ( supine systolic blood pressure le 80 mmHg ) unresponsive fluid challenge Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No HIV infection CD4 count less 200/mm3 No significant risk seizures No unstable psychiatric disorder Weight great 40 kg No prior allergic severe adverse reaction study drug member quinolone betalactam class antibacterials No disorder disease would preclude study PRIOR CONCURRENT THERAPY : Biologic therapy : No prior sargramostim ( GMCSF ) filgrastim ( GCSF ) current course chemotherapy Concurrent GMCSF GCSF allow neutropenia last least 3 day Chemotherapy : See Disease Characteristics Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify Other : No prior treatment protocol No prior prophylactic antiinfectives acyclovir sulfamethoxazole trimethoprim At least 72 hour since prior systemic antibiotic ( except prophylactic sulfamethoxazole trimethoprim ) At least 30 day since prior experimental drug medical device ( except drug currently market United States treatment malignancy ) No concurrent systemic antibacterial agent No concurrent topical antimicrobial agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>stage I adult Hodgkin lymphoma</keyword>
	<keyword>stage II adult Hodgkin lymphoma</keyword>
	<keyword>stage III adult Hodgkin lymphoma</keyword>
	<keyword>stage IV adult Hodgkin lymphoma</keyword>
	<keyword>recurrent adult Hodgkin lymphoma</keyword>
	<keyword>stage I cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage II cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage III cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage IV cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>recurrent cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage 0 chronic lymphocytic leukemia</keyword>
	<keyword>stage I chronic lymphocytic leukemia</keyword>
	<keyword>stage II chronic lymphocytic leukemia</keyword>
	<keyword>stage III chronic lymphocytic leukemia</keyword>
	<keyword>stage IV chronic lymphocytic leukemia</keyword>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>recurrent adult acute lymphoblastic leukemia</keyword>
	<keyword>relapse chronic myelogenous leukemia</keyword>
	<keyword>refractory chronic lymphocytic leukemia</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>chronic phase chronic myelogenous leukemia</keyword>
	<keyword>accelerated phase chronic myelogenous leukemia</keyword>
	<keyword>blastic phase chronic myelogenous leukemia</keyword>
	<keyword>meningeal chronic myelogenous leukemia</keyword>
	<keyword>adult acute myeloid leukemia remission</keyword>
	<keyword>adult acute lymphoblastic leukemia remission</keyword>
	<keyword>fever , sweat , hot flash</keyword>
	<keyword>progressive hairy cell leukemia , initial treatment</keyword>
	<keyword>refractory hairy cell leukemia</keyword>
	<keyword>stage I grade 1 follicular lymphoma</keyword>
	<keyword>stage I grade 2 follicular lymphoma</keyword>
	<keyword>stage I grade 3 follicular lymphoma</keyword>
	<keyword>stage I adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage I adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage I adult diffuse large cell lymphoma</keyword>
	<keyword>stage I adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage I adult lymphoblastic lymphoma</keyword>
	<keyword>stage I adult Burkitt lymphoma</keyword>
	<keyword>chronic myelomonocytic leukemia</keyword>
	<keyword>T-cell large granular lymphocyte leukemia</keyword>
	<keyword>acute undifferentiated leukemia</keyword>
	<keyword>stage III grade 1 follicular lymphoma</keyword>
	<keyword>stage III grade 2 follicular lymphoma</keyword>
	<keyword>stage III grade 3 follicular lymphoma</keyword>
	<keyword>stage III adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage III adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage III adult diffuse large cell lymphoma</keyword>
	<keyword>stage III adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage III adult lymphoblastic lymphoma</keyword>
	<keyword>stage III adult Burkitt lymphoma</keyword>
	<keyword>stage IV grade 1 follicular lymphoma</keyword>
	<keyword>stage IV grade 2 follicular lymphoma</keyword>
	<keyword>stage IV grade 3 follicular lymphoma</keyword>
	<keyword>stage IV adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage IV adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult lymphoblastic lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>recurrent grade 1 follicular lymphoma</keyword>
	<keyword>recurrent grade 2 follicular lymphoma</keyword>
	<keyword>recurrent grade 3 follicular lymphoma</keyword>
	<keyword>recurrent adult diffuse small cleave cell lymphoma</keyword>
	<keyword>recurrent adult diffuse mixed cell lymphoma</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult lymphoblastic lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>stage I adult T-cell leukemia/lymphoma</keyword>
	<keyword>stage II adult T-cell leukemia/lymphoma</keyword>
	<keyword>stage III adult T-cell leukemia/lymphoma</keyword>
	<keyword>stage IV adult T-cell leukemia/lymphoma</keyword>
	<keyword>recurrent adult T-cell leukemia/lymphoma</keyword>
	<keyword>secondary acute myeloid leukemia</keyword>
	<keyword>primary central nervous system non-Hodgkin lymphoma</keyword>
	<keyword>neutropenia</keyword>
	<keyword>infection</keyword>
	<keyword>prolymphocytic leukemia</keyword>
	<keyword>AIDS-related peripheral/systemic lymphoma</keyword>
	<keyword>AIDS-related primary CNS lymphoma</keyword>
	<keyword>intraocular lymphoma</keyword>
	<keyword>stage I mantle cell lymphoma</keyword>
	<keyword>contiguous stage II grade 1 follicular lymphoma</keyword>
	<keyword>contiguous stage II grade 2 follicular lymphoma</keyword>
	<keyword>contiguous stage II grade 3 follicular lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse small cleave cell lymphoma</keyword>
	<keyword>contiguous stage II mantle cell lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>contiguous stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>contiguous stage II adult Burkitt lymphoma</keyword>
	<keyword>contiguous stage II adult lymphoblastic lymphoma</keyword>
	<keyword>noncontiguous stage II grade 1 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II grade 2 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II grade 3 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse small cleave cell lymphoma</keyword>
	<keyword>noncontiguous stage II mantle cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult Burkitt lymphoma</keyword>
	<keyword>noncontiguous stage II adult lymphoblastic lymphoma</keyword>
	<keyword>stage III mantle cell lymphoma</keyword>
	<keyword>stage IV mantle cell lymphoma</keyword>
	<keyword>recurrent mantle cell lymphoma</keyword>
	<keyword>angioimmunoblastic T-cell lymphoma</keyword>
	<keyword>anaplastic large cell lymphoma</keyword>
	<keyword>stage I mycosis fungoides/Sezary syndrome</keyword>
	<keyword>stage II mycosis fungoides/Sezary syndrome</keyword>
	<keyword>stage III mycosis fungoides/Sezary syndrome</keyword>
	<keyword>stage IV mycosis fungoides/Sezary syndrome</keyword>
	<keyword>recurrent mycosis fungoides/Sezary syndrome</keyword>
	<keyword>noncontiguous stage II small lymphocytic lymphoma</keyword>
	<keyword>noncontiguous stage II marginal zone lymphoma</keyword>
	<keyword>recurrent marginal zone lymphoma</keyword>
	<keyword>recurrent small lymphocytic lymphoma</keyword>
	<keyword>stage I marginal zone lymphoma</keyword>
	<keyword>stage I small lymphocytic lymphoma</keyword>
	<keyword>stage III small lymphocytic lymphoma</keyword>
	<keyword>stage III marginal zone lymphoma</keyword>
	<keyword>stage IV small lymphocytic lymphoma</keyword>
	<keyword>stage IV marginal zone lymphoma</keyword>
	<keyword>contiguous stage II marginal zone lymphoma</keyword>
	<keyword>contiguous stage II small lymphocytic lymphoma</keyword>
	<keyword>extranodal marginal zone B-cell lymphoma mucosa-associated lymphoid tissue</keyword>
	<keyword>nodal marginal zone B-cell lymphoma</keyword>
	<keyword>splenic marginal zone lymphoma</keyword>
</DOC>